These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36980729)

  • 1. Conditioned Media from Head and Neck Cancer Cell Lines and Serum Samples from Head and Neck Cancer Patients Drive Catabolic Pathways in Cultured Muscle Cells.
    Saroul N; Tardif N; Pereira B; Dissard A; Montrieul L; Sanchez P; Salles J; Petersen JE; Jakobson T; Gilain L; Mom T; Boirie Y; Rooyakers O; Walrand S
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of conditioned media from murine lung cancer cells and human tumor cells on cultured myotubes.
    Guigni BA; van der Velden J; Kinsey CM; Carson JA; Toth MJ
    Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E22-E32. PubMed ID: 31689144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle metabolic stress determines cancer cachexia severity in mice.
    Alves C; Goodyear L; Brum P
    Front Physiol; 2022; 13():1033932. PubMed ID: 36518110
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effects of 25-hydroxy- and 1α,25-dihydroxy-vitamin D
    Sustova H; De Feudis M; Reano S; Alves Teixeira M; Valle I; Zaggia I; Agosti E; Prodam F; Filigheddu N
    Acta Physiol (Oxf); 2019 Jul; 226(3):e13269. PubMed ID: 30834670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of cachexia in newly diagnosed head and neck cancer patients: An exploratory study.
    Jager-Wittenaar H; Dijkstra PU; Dijkstra G; Bijzet J; Langendijk JA; van der Laan BFAM; Roodenburg JLN
    Nutrition; 2017 Mar; 35():114-118. PubMed ID: 28241978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90.
    Wu HY; Trevino JG; Fang BL; Riner AN; Vudatha V; Zhang GH; Li YP
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
    Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
    Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFIT2-depleted metastatic oral squamous cell carcinoma cells induce muscle atrophy and cancer cachexia in mice.
    Lai KC; Hong ZX; Hsieh JG; Lee HJ; Yang MH; Hsieh CH; Yang CH; Chen YR
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1314-1328. PubMed ID: 35170238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
    Seto DN; Kandarian SC; Jackman RW
    J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin.
    Liu C; Feng X; Wang B; Wang X; Wang C; Yu M; Cao G; Wang H
    Cancer Sci; 2018 Mar; 109(3):688-698. PubMed ID: 29284199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells.
    Yang J; Zhang Z; Zhang Y; Ni X; Zhang G; Cui X; Liu M; Xu C; Zhang Q; Zhu H; Yan J; Zhu VF; Luo Y; Hagan JP; Li Z; Fang J; Jatoi A; Fernandez-Zapico ME; Zheng L; Edil BH; Bronze MS; Houchen CW; Li YP; Li M
    Gastroenterology; 2019 Feb; 156(3):722-734.e6. PubMed ID: 30342032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pancreatic tumour organoid-derived factors enhance myogenic differentiation.
    Vaes RDW; van Dijk DPJ; Farshadi EA; Olde Damink SWM; Rensen SS; Langen RC
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1302-1313. PubMed ID: 35146962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Release of Tumor-Derived Factors Improves the Modeling of Cachexia in Muscle Cell Culture.
    Jackman RW; Floro J; Yoshimine R; Zitin B; Eiampikul M; El-Jack K; Seto DN; Kandarian SC
    Front Physiol; 2017; 8():738. PubMed ID: 28993738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway.
    Liu D; Qiao X; Ge Z; Shang Y; Li Y; Wang W; Chen M; Si S; Chen SZ
    Skelet Muscle; 2019 Mar; 9(1):8. PubMed ID: 30922397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Toll-Like Receptor/MyD88/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting during Cancer Cachexia.
    Bohnert KR; Goli P; Roy A; Sharma AK; Xiong G; Gallot YS; Kumar A
    Mol Cell Biol; 2019 Aug; 39(15):. PubMed ID: 31138662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cut-off values for low skeletal muscle mass at the level of the third cervical vertebra (C3) in patients with head and neck cancer.
    Chargi N; Bril SI; Smid EJ; de Jong PA; de Bree R
    Quant Imaging Med Surg; 2022 Jun; 12(6):3024-3033. PubMed ID: 35655816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myostatin is a novel tumoral factor that induces cancer cachexia.
    Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
    Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBPβ promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia.
    AlSudais H; Rajgara R; Saleh A; Wiper-Bergeron N
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):743-757. PubMed ID: 35014202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.